In 2021, the market for Intraocular Lens (IOL) worldwide was worth $4.5 billion US dollars. AMR Group projects that the market will reach US$ 6.7 billion by 2031, growing at a CAGR of 5.2 percent between 2022 and 2031.
An Intraocular Lens (IOL) is an artificial lens that is implanted inside the eye to replace the natural lens that has been removed during cataract surgery or to correct vision problems. The IOL is a small, clear plastic or silicone lens that is placed behind the iris, in the same position as the natural lens. The IOLs come in different sizes, shapes, and materials, depending on the patient's individual needs and preferences. IOLs can correct various vision problems such as nearsightedness, farsightedness, and astigmatism.
There are two main types of IOLs: monofocal and multifocal. Monofocal IOLs have a single focus and are used to correct either nearsightedness or farsightedness. Multifocal IOLs, on the other hand, have multiple focal points and can provide clear vision at multiple distances, eliminating the need for glasses or contacts. IOLs have revolutionized cataract surgery and vision correction, allowing patients to regain clear vision and improve their quality of life. With advances in technology, newer IOLs have been developed that can correct higher levels of astigmatism and provide better vision outcomes for patients with other eye conditions.

Get The Details: https://analyticsmarketresearc....h.com/reports/intrao